Integrins and proximal signaling mechanisms in cardiovascular disease

Frontiers in Bioscience

Volumn 14, Issue 6, 2009, Pages 2307-2334

  Lal, Hind ^a   Verma, Suresh K ^a   Foster, Donald M ^b   Golden, Honey B ^a   Reneau, John C ^a   Watson, Linley E ^c   Singh, Hitesh ^d   Dostal, David E ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Division of Cardiology   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Cardiac hypertrophy cardiomyocytes; Caveolin; Fibroblasts; Focal adhesion kinase; Integrin linked kinase; Integrins; Mitogen activated protein kinase; Review

Indexed keywords

INTEGRIN;

CARDIOVASCULAR DISEASE; CELL MEMBRANE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

CARDIOVASCULAR DISEASES; CELL MEMBRANE; HUMANS; INTEGRINS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION;

EID: 63849307598     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3381     Document Type: Article

References (284)

1. Tanentzapf, G., D. Devenport, D. Godt & N. H. Brown: Integrin-dependent anchoring of a stem-cell niche. Nat Cell Biol, 9, 1413-1418 (2007). (Pubitemid 350201754)
2. Hynes, R. O.: Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-87 (2002. (Pubitemid 35283958)
3. Aplin, A. E., A. Howe, S. K. Alahari & R. L. Juliano: Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev, 50, 197-263 (1998). (Pubitemid 28304026)
4. Rupp, P. A. & C. D. Little: Integrins in vascular development. Circ Res, 89, 566-72 (2001). (Pubitemid 32924210)
5. Giancotti, F. G. & E. Ruoslahti: Integrin signaling. Science, 285, 1028-32 (1999).
6. Martinez-Lemus, L. A., X. Wu, E. Wilson, M. A. Hill, G. E. Davis, M. J. Davis & G. A. Meininger: Integrins as unique receptors for vascular control. J Vasc Res, 40, 211-33 (2003). (Pubitemid 36980724)
7. Ross, R. S.: Molecular and mechanical synergy: crosstalk between integrins and growth factor receptors. Cardiovasc Res, 63, 381-90 (2004). (Pubitemid 38970182)
8. Ruegg, C. & A. Mariotti: Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci, 60, 1135-57 (2003). (Pubitemid 36791917)
9. Schoenwaelder, S. M. & K. Burridge: Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol, 11, 274-86 (1999). (Pubitemid 29164045)
10. Aikawa, R., T. Nagai, S. Kudoh, Y. Zou, M. Tanaka, M. Tamura, H. Akazawa, H. Takano, R. Nagai & I. Komuro: Integrins play a critical role in mechanical stress-induced p38 MAPK activation. Hypertension, 39, 233-8 (2002). (Pubitemid 34165221)
11. Shyy, J. Y. & S. Chien: Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol, 9, 707-13 (1997). (Pubitemid 27424928)
12. Laser, M., C. D. Willey, W. Jiang, G. t. Cooper, D. R. Menick, M. R. Zile & D. Kuppuswamy: Integrin activation and focal complex formation in cardiac hypertrophy. J Biol Chem, 275, 35624-30 (2000).
13. Chen, K. D., Y. S. Li, M. Kim, S. Li, S. Yuan, S. Chien & J. Y. Shyy: Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem, 274, 18393-400 (1999).
14. Galbraith, C. G., K. M. Yamada & M. P. Sheetz: The relationship between force and focal complex development. J Cell Biol, 159, 695-705 (2002).
15. Kawabe, J., S. Okumura, M. C. Lee, J. Sadoshima & Y. Ishikawa: Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol, 286, H1845-52 (2004). (Pubitemid 38525474)
16. Ruwhof, C. & A. van der Laarse: Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res, 47, 23-37 (2000). (Pubitemid 30408547)
17. Muller, J. M., W. M. Chilian & M. J. Davis: Integrin signaling transduces shear stress-dependent vasodilation of coronary arterioles. Circ Res, 80, 320-6 (1997). (Pubitemid 27093345)
18. MacKenna, D., S. R. Summerour & F. J. Villarreal: Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res, 46, 257-63 (2000). (Pubitemid 30204597)
19. Curley, G. P., H. Blum & M. J. Humphries: Integrin antagonists. Cell Mol Life Sci, 56, 427-41 (1999). (Pubitemid 29520833)
20. Hynes, R. O.: Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-25 (1992).
21. Hynes, R. O.: A reevaluation of integrins as regulators of angiogenesis. Nat Med, 8, 918-21 (2002). (Pubitemid 35033683)
22. Shai, S. Y., A. E. Harpf, C. J. Babbitt, M. C. Jordan, M. C. Fishbein, J. Chen, M. Omura, T. A. Leil, K. D. Becker, M. Jiang, D. J. Smith, S. R. Cherry, J. C. Loftus & R. S. Ross: Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res, 90, 458-64 (2002). (Pubitemid 34633916)
23. Valencik, M. L., D. Zhang, B. Punske, P. Hu, J. A. McDonald & S. E. Litwin: Integrin activation in the heart: a link between electrical and contractile dysfunction? Circ Res, 99, 1403-10 (2006). (Pubitemid 44949676)
24. Valencik, M. L. & J. A. McDonald: Cardiac expression of a gain-of-function alpha (5)-integrin results in perinatal lethality. Am J Physiol Heart Circ Physiol, 280, H361-7 (2001).
25. Ren, J., J. Avery, H. Zhao, J. G. Schneider, F. P. Ross & A. J. Muslin: Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation. J Mol Cell Cardiol, 42, 367-77 (2007). (Pubitemid 46135609)
26. Valencik, M. L., R. S. Keller, J. C. Loftus & J. A. McDonald: A lethal perinatal cardiac phenotype resulting from altered integrin function in cardiomyocytes. J Card Fail, 8, 262-72 (2002).
27. Wei, L., L. Wang, J. A. Carson, J. E. Agan, K. Imanaka-Yoshida & R. J. Schwartz: beta1 integrin and organized actin filaments facilitate cardiomyocyte-specific RhoA-dependent activation of the skeletal alpha-actin promoter. Faseb J, 15, 785-96 (2001). (Pubitemid 32245997)
28. Heidkamp, M. C., A. L. Bayer, J. A. Kalina, D. M. Eble & A. M. Samarel: GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes. Circ Res, 90, 1282-9 (2002). (Pubitemid 34787410)
29. Ross, R. S.: The extracellular connections: the role of integrins in myocardial remodeling. J Card Fail, 8, S326-31 (2002). (Pubitemid 36083079)
30. Ross, R. S. & T. K. Borg: Integrins and the myocardium. Circ Res, 88, 1112-9 (2001). (Pubitemid 34132510)
31. Maitra, N., I. L. Flink, J. J. Bahl & E. Morkin: Expression of alpha and beta integrins during terminal differentiation of cardiomyocytes. Cardiovasc Res, 47, 715-25 (2000).
32. Brancaccio, M., S. Cabodi, A. M. Belkin, G. Collo, V. E. Koteliansky, D. Tomatis, F. Altruda, L. Silengo & G. Tarone: Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development. Cell Adhes Commun, 5, 193-205 (1998).
33. Van der Flier, A., A. C. Gaspar, S. Thorsteinsdottir, C. Baudoin, E. Groeneveld, C. L. Mummery & A. Sonnenberg: Spatial and temporal expression of the beta1D integrin during mouse development. Dev Dyn, 210, 472-86 (1997). (Pubitemid 27516672)
34. Pham, C. G., A. E. Harpf, R. S. Keller, H. T. Vu, S. Y. Shai, J. C. Loftus & R. S. Ross: Striated muscle-specific beta (1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol Heart Circ Physiol, 279, H2916-26 (2000). (Pubitemid 32005882)
35. Belkin, A. M., S. F. Retta, O. Y. Pletjushkina, F. Balzac, L. Silengo, R. Fassler, V. E. Koteliansky, K. Burridge & G. Tarone: Muscle beta1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing. J Cell Biol, 139, 1583-95 (1997). (Pubitemid 28013677)
36. Nunohiro, T., N. Ashizawa, K. Graf, W. A. Hsueh & K. Yano: Angiotensin II promotes integrin-mediated collagen gel contraction by adult rat cardiac fibroblasts. Jpn Heart J, 40, 461-9 (1999). (Pubitemid 29473838)
37. Stawowy, P., C. Margeta, F. Blaschke, C. Lindschau, C. Spencer-Hansch, M. Leitges, G. Biagini, E. Fleck & K. Graf: Protein kinase C epsilon mediates angiotensin II-induced activation of beta1-integrins in cardiac fibroblasts. Cardiovasc Res, 67, 50-9 (2005). (Pubitemid 40798292)
38. Cleutjens, J. P., M. J. Verluyten, J. F. Smiths & M. J. Daemen: Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol, 147, 325-38 (1995).
39. Weber, K. T.: Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation, 96, 4065-82 (1997).
40. Graf, K., Y. S. Do, N. Ashizawa, W. P. Meehan, C. M. Giachelli, C. C. Marboe, E. Fleck & W. A. Hsueh: Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation, 96, 3063-71 (1997). (Pubitemid 27500109)
41. Stawowy, P., F. Blaschke, P. Pfautsch, S. Goetze, F. Lippek, B. Wollert-Wulf, E. Fleck & K. Graf: Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail, 4, 139-46 (2002). (Pubitemid 34233499)
42. Burgess, M. L., L. Terracio, T. Hirozane & T. K. Borg: Differential integrin expression by cardiac fibroblasts from hypertensive and exercise-trained rat hearts. Cardiovasc Pathol, 11, 78-87 (2002). (Pubitemid 34273662)
43. Burgess, M. L., W. E. Carver, L. Terracio, S. P. Wilson, M. A. Wilson & T. K. Borg: Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res, 74, 291-8 (1994). (Pubitemid 24029161)
44. Ashizawa, N., K. Graf, Y. S. Do, T. Nunohiro, C. M. Giachelli, W. P. Meehan, T. L. Tuan & W. A. Hsueh: Osteopontin is produced by rat cardiac fibroblasts and mediates A (II)-induced DNA synthesis and collagen gel contraction. J Clin Invest, 98, 2218-27 (1996). (Pubitemid 26394194)
45. Kawano, H., R. J. Cody, K. Graf, S. Goetze, Y. Kawano, J. Schnee, R. E. Law & W. A. Hsueh: Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts. Hypertension, 35, 273-9 (2000). (Pubitemid 30054185)
46. Mould, A. P. & M. J. Humphries: Regulation of integrin function through conformational complexity: not simply a knee-jerk reaction? Curr Opin Cell Biol, 16, 544-51 (2004). (Pubitemid 39201239)
47. Arnaout, M. A., B. Mahalingam & J. P. Xiong: Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol, 21, 381-410 (2005). (Pubitemid 41740640)
48. Qin, J., O. Vinogradova & E. F. Plow: Integrin bidirectional signaling: a molecular view. PLoS Biol, 2, e169 (2004).
49. Calderwood, D. A.: Integrin activation. J Cell Sci, 117, 657-66 (2004). (Pubitemid 38268081)
50. Liu, S., D. A. Calderwood & M. H. Ginsberg: Integrin cytoplasmic domain-binding proteins. J Cell Sci, 113 (Pt 20) 3563-71 (2000).
51. Zamir, E. & B. Geiger: Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci, 114, 3583-90 (2001). (Pubitemid 33041040)
52. Schwartz, M. A., M. D. Schaller & M. H. Ginsberg: Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol, 11, 549-99 (1995). (Pubitemid 26019614)
53. Davies, P. F.: Flow-mediated endothelial mechanotransduction. Physiol Rev, 75, 519-60 (1995).
54. Chien, S., S. Li & Y. J. Shyy: Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension, 31, 162-9 (1998).
55. Roovers, K., G. Davey, X. Zhu, M. E. Bottazzi & R. K. Assoian: Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol Biol Cell, 10, 3197-204 (1999). (Pubitemid 29489555)
56. Aplin, A. E., S. A. Stewart, R. K. Assoian & R. L. Juliano: Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol, 153, 273-82 (2001).
57. Resnick, N., H. Yahav, A. Shay-Salit, M. Shushy, S. Schubert, L. C. Zilberman & E. Wofovitz: Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol, 81, 177-99 (2003). (Pubitemid 36551198)
58. Geiger, B. & A. Bershadsky: Assembly and mechanosensory function of focal contacts. Curr Opin Cell Biol, 13, 584-92 (2001). (Pubitemid 32817017)
59. Bershadsky, A. D., N. Q. Balaban & B. Geiger: Adhesion-dependent cell mechanosensitivity. Annu Rev Cell Dev Biol, 19, 677-95 (2003). (Pubitemid 37487365)
60. Nadruz, W. Jr., M. A. Corat, T. M. Marin, G. A. Guimaraes Pereira & K. G. Franchini: Focal adhesion kinase mediates MEF2 and c-Jun activation by stretch: role in the activation of the cardiac hypertrophic genetic program. Cardiovasc Res, 68, 87-97 (2005). (Pubitemid 41253559)
61. Li, F., Y. Zhang & C. Wu: Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats. J Cell Sci, 112 (Pt 24), 4589-99 (1999). (Pubitemid 30034808)
62. White, J. M.: ADAMs: modulators of cell-cell and cellmatrix interactions. Curr Opin Cell Biol, 15, 598-606 (2003). (Pubitemid 37176969)
63. Tschumperlin, D. J., G. Dai, I. V. Maly, T. Kikuchi, L. H. Laiho, A. K. McVittie, K. J. Haley, C. M. Lilly, P. T. So, D. A. Lauffenburger, R. D. Kamm & J. M. Drazen: Mechanotransduction through growth-factor shedding into the extracellular space. Nature, 429, 83-6 (2004). (Pubitemid 38620555)
64. Sadoshima, J., Y. Xu, H. S. Slayter & S. Izumo: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell, 75, 977-84 (1993). (Pubitemid 24014554)
65. Yamazaki, T., I. Komuro, S. Kudoh, Y. Zou, I. Shiojima, Y. Hiroi, T. Mizuno, K. Maemura, H. Kurihara, R. Aikawa, H. Takano & Y. Yazaki: Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem, 271, 3221-8 (1996). (Pubitemid 26055625)
66. Jia, N., H. Okamoto, T. Shimizu, S. Chiba, Y. Matsui, T. Sugawara, M. Akino & A. Kitabatake: A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression. Hypertens Res, 26, 737-42 (2003). (Pubitemid 37258662)
67. Zou, Y., H. Akazawa, Y. Qin, M. Sano, H. Takano, T. Minamino, N. Makita, K. Iwanaga, W. Zhu, S. Kudoh, H. Toko, K. Tamura, M. Kihara, T. Nagai, A. Fukamizu, S. Umemura, T. Iiri, T. Fujita & I. Komuro: Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol, 6, 499-506 (2004). (Pubitemid 38786592)
68. Gratton, J. P., P. Bernatchez & W. C. Sessa: Caveolae and caveolins in the cardiovascular system. Circ Res, 94, 1408-17 (2004). (Pubitemid 38780313)
69. Pike, L. J.: Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim Biophys Acta, 1746, 260-73 (2005). (Pubitemid 41818991)
70. Yuan, Z., T. Cai, J. Tian, A. V. Ivanov, D. R. Giovannucci & Z. Xie: Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell, 16, 4034-45 (2005). (Pubitemid 41262876)
71. Foster, L. J., C. L. De Hoog & M. Mann: Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A, 100, 5813-8 (2003). (Pubitemid 36576890)
72. Nicolau, D. V. Jr., K. Burrage, R. G. Parton & J. F. Hancock: Identifying optimal lipid raft characteristics required to promote nanoscale protein-protein interactions on the plasma membrane. Mol Cell Biol, 26, 313-23 (2006).
73. Polozov, I. V. & K. Gawrisch: Characterization of the liquid-ordered state by proton MAS NMR. Biophys J, 90, 2051-61 (2006).
74. Caroni, P.: New EMBO members' review: actin cytoskeleton regulation through modulation of PI (4, 5) P (2)rafts. Embo J, 20, 4332-6 (2001). (Pubitemid 32772026)
75. Del Pozo, M. A., N. B. Alderson, W. B. Kiosses, H. H. Chiang, R. G. Anderson & M. A. Schwartz: Integrins regulate Rac targeting by internalization of membrane domains. Science, 303, 839-42 (2004). (Pubitemid 38174662)
76. Vasanji, A., P. K. Ghosh, L. M. Graham, S. J. Eppell & P. L. Fox: Polarization of plasma membrane microviscosity during endothelial cell migration. Dev Cell, 6, 29-41 (2004). (Pubitemid 38089203)
77. Gagnoux-Palacios, L., M. Dans, W. van't Hof, A. Mariotti, A. Pepe, G. Meneguzzi, M. D. Resh & F. G. Giancotti: Compartmentalization of integrin alpha6beta4 signaling in lipid rafts. J Cell Biol, 162, 1189-96 (2003). (Pubitemid 37210876)
78. Palade, G.: Fine structure of blood capillaries. J Appl Phys, 24, 1424-1436 (1953).
79. Razani, B., A. Schlegel & M. P. Lisanti: Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci, 113 (Pt 12), 2103-9 (2000). (Pubitemid 30426825)
80. Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. S. Ying, J. R. Glenney & R. G. Anderson: Caveolin, a protein component of caveolae membrane coats. Cell, 68, 673-82 (1992).
81. Pelkmans, L., D. Puntener & A. Helenius: Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science, 296, 535-9 (2002). (Pubitemid 34408673)
82. Fielding, C. J. & P. E. Fielding: Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev, 49, 251-64 (2001). (Pubitemid 32718687)
83. Thyberg, J.: Caveolin-1 and caveolae act as regulators of mitogenic signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 23, 1481-3 (2003). (Pubitemid 37108185)
84. Cao, H., W. E. Courchesne & C. C. Mastick: A phosphotyrosine- dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J Biol Chem, 277, 8771-4 (2002). (Pubitemid 34952941)
85. Lee, H., D. Volonte, F. Galbiati, P. Iyengar, D. M. Lublin, D. B. Bregman, M. T. Wilson, R. Campos-Gonzalez, B. Bouzahzah, R. G. Pestell, P. E. Scherer & M. P. Lisanti: Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol, 14, 1750-75 (2000).
86. Cohen, A. W., D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. Pereira de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, B. Tang, L. A. Jelicks, S. M. Factor, V. Shtutin, H. B. Tanowitz & M. P. Lisanti: Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol, 284, C457-74 (2003). (Pubitemid 36120083)
87. Woodman, S. E., D. S. Park, A. W. Cohen, M. W. Cheung, M. Chandra, J. Shirani, B. Tang, L. A. Jelicks, R. N. Kitsis, G. J. Christ, S. M. Factor, H. B. Tanowitz & M. P. Lisanti: Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem, 277, 38988-97 (2002). (Pubitemid 35154765)
88. Park, D. S., S. E. Woodman, W. Schubert, A. W. Cohen, P. G. Frank, M. Chandra, J. Shirani, B. Razani, B. Tang, L. A. Jelicks, S. M. Factor, L. M. Weiss, H. B. Tanowitz & M. P. Lisanti: Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol, 160, 2207-17 (2002). (Pubitemid 34663411)
89. Wary, K. K., A. Mariotti, C. Zurzolo & F. G. Giancotti: A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell, 94, 625-34 (1998). (Pubitemid 28427581)
90. Wei, Y., M. Lukashev, D. I. Simon, S. C. Bodary, S. Rosenberg, M. V. Doyle & H. A. Chapman: Regulation of integrin function by the urokinase receptor. Science, 273, 1551-5 (1996). (Pubitemid 26301666)
91. Wei, Y., X. Yang, Q. Liu, J. A. Wilkins & H. A. Chapman: A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol, 144, 1285-94 (1999). (Pubitemid 29157305)
92. Bergdahl, A. & K. Sward: Caveolae-associated signalling in smooth muscle. Can J Physiol Pharmacol, 82, 289-99 (2004). (Pubitemid 39093694)
93. Li, S., J. Couet & M. P. Lisanti: Src tyrosine kinases, Galpha subunits, and H-Ras share a common membraneanchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem, 271, 29182-90 (1996). (Pubitemid 26382628)
94. Couet, J., S. Li, T. Okamoto, T. Ikezu & M. P. Lisanti: Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem, 272, 6525-33 (1997). (Pubitemid 27118133)
95. Geiger, B. & A. Bershadsky: Exploring the neighborhood: adhesion-coupled cell mechanosensors. Cell, 110, 139-42 (2002). (Pubitemid 34876542)
96. Riveline, D., E. Zamir, N. Q. Balaban, U. S. Schwarz, T. Ishizaki, S. Narumiya, Z. Kam, B. Geiger & A. D. Bershadsky: Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol, 153, 1175-86 (2001).
97. Smilenov, L. B., A. Mikhailov, R. J. Pelham, E. E. Marcantonio & G. G. Gundersen: Focal adhesion motility revealed in stationary fibroblasts. Science, 286, 1172-4 (1999).
98. Tsutsui, H., K. Ishihara & G. t. Cooper: Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science, 260, 682-7 (1993). (Pubitemid 23167592)
99. Webb, D. J., J. T. Parsons & A. F. Horwitz: Adhesion assembly, disassembly and turnover in migrating cells - over and over and over again. Nat Cell Biol, 4, E97-100 (2002). (Pubitemid 34308850)
100. Pankov, R., E. Cukierman, B. Z. Katz, K. Matsumoto, D. C. Lin, S. Lin, C. Hahn & K. M. Yamada: Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha (5)beta (1) integrins promotes early fibronectin fibrillogenesis. J Cell Biol, 148, 1075-90 (2000).
101. Zamir, E., M. Katz, Y. Posen, N. Erez, K. M. Yamada, B. Z. Katz, S. Lin, D. C. Lin, A. Bershadsky, Z. Kam & B. Geiger: Dynamics and segregation of cell-matrix adhesions in cultured fibroblasts. Nat Cell Biol, 2, 191-6 (2000).
102. Ulrich, M. M., A. M. Janssen, M. J. Daemen, L. Rappaport, J. L. Samuel, F. Contard, J. F. Smits & J. P. Cleutjens: Increased expression of fibronectin isoforms after myocardial infarction in rats. J Mol Cell Cardiol, 29, 2533-43 (1997). (Pubitemid 27404445)
103. Magnusson, M. K. & D. F. Mosher: Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol, 18, 1363-70 (1998). (Pubitemid 28421872)
104. Fayet, C., M. P. Bendeck & A. I. Gotlieb: Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury. Cardiovasc Pathol, 16, 203-11 (2007). (Pubitemid 47048753)
105. Samarel, A. M.: Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am J Physiol Heart Circ Physiol, 289, H2291-301 (2005). (Pubitemid 41698534)
106. Hanks, S. K., M. B. Calalb, M. C. Harper & S. K. Patel: Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci U S A, 89, 8487-91 (1992).
107. Schaller, M. D., C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds & J. T. Parsons: pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A, 89, 5192-6 (1992).
108. Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada & T. Yamamoto: Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature, 377, 539-44 (1995).
109. Ilic, D., C. H. Damsky & T. Yamamoto: Focal adhesion kinase: at the crossroads of signal transduction. J Cell Sci, 110 (Pt 4), 401-7 (1997). (Pubitemid 27116721)
110. Owen, J. D., P. J. Ruest, D. W. Fry & S. K. Hanks: Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol, 19, 4806-18 (1999). (Pubitemid 29289519)
111. Gilmore, A. P. & L. H. Romer: Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell, 7, 1209-24 (1996). (Pubitemid 26260738)
112. Cary, L. A., J. F. Chang & J. L. Guan: Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci, 109 (Pt 7)1787-94 (1996). (Pubitemid 26248624)
113. Zhao, J., Z. C. Bian, K. Yee, B. P. Chen, S. Chien & J. L. Guan: Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Mol Cell, 11, 1503-15 (2003). (Pubitemid 36776537)
114. Whitney, G. S., P. Y. Chan, J. Blake, W. L. Cosand, M. G. Neubauer, A. Aruffo & S. B. Kanner: Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK. DNA Cell Biol, 12, 823-30 (1993). (Pubitemid 24295358)
115. Fiedorek, F. T., Jr. & E. S. Kay: Mapping of the focal adhesion kinase (Fadk)gene to mouse chromosome 15 and human chromosome 8. Mamm Genome, 6, 123-6 (1995).
116. Agochiya, M., V. G. Brunton, D. W. Owens, E. K. Parkinson, C. Paraskeva, W. N. Keith & M. C. Frame: Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene, 18, 5646-53 (1999). (Pubitemid 29497599)
117. Schaller, M. D.: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta, 1540, 1-21 (2001). (Pubitemid 32710044)
118. Gervais, F. G., N. A. Thornberry, S. C. Ruffolo, D. W. Nicholson & S. Roy: Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide. J Biol Chem, 273, 17102-8 (1998). (Pubitemid 28311745)
119. Torsoni, A. S., S. S. Constancio, W. Nadruz, Jr., S. K. Hanks & K. G. Franchini: Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ Res, 93, 140-7 (2003). (Pubitemid 36919701)
120. Lal, H., S. K. Verma, M. Smith, R. S. Guleria, G. Lu, D. M. Foster & D. E. Dostal: Stretch-induced MAP kinase activation in cardiac myocytes: differential regulation through beta1-integrin and focal adhesion kinase. J Mol Cell Cardiol, 43, 137-47 (2007). (Pubitemid 47069384)
121. Salazar, E. P. & E. Rozengurt: Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J Biol Chem, 276, 17788-95 (2001).
122. Eble, D. M., J. B. Strait, G. Govindarajan, J. Lou, K. L. Byron & A. M. Samarel: Endothelin-induced cardiac myocyte hypertrophy: role for focal adhesion kinase. Am J Physiol Heart Circ Physiol, 278, H1695-707 (2000). (Pubitemid 30395584)
123. Taylor, J. M., J. D. Rovin & J. T. Parsons: A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes. J Biol Chem, 275, 19250-7 (2000). (Pubitemid 30422897)
124. Kudoh, S., I. Komuro, Y. Hiroi, Y. Zou, K. Harada, T. Sugaya, N. Takekoshi, K. Murakami, T. Kadowaki & Y. Yazaki: Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice. J Biol Chem, 273, 24037-43 (1998). (Pubitemid 28435745)
125. Sawada, Y., M. Tamada, B. J. Dubin-Thaler, O. Cherniavskaya, R. Sakai, S. Tanaka & M. P. Sheetz: Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell, 127, 1015-26 (2006). (Pubitemid 44803062)
126. Ilic, D., B. Kovacic, S. McDonagh, F. Jin, C. Baumbusch, D. G. Gardner & C. H. Damsky: Focal adhesion kinase is required for blood vessel morphogenesis. Circ Res, 92, 300-7 (2003). (Pubitemid 36258552)
127. Peng, X., H. Ueda, H. Zhou, T. Stokol, T. L. Shen, A. Alcaraz, T. Nagy, J. D. Vassalli & J. L. Guan: Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice. Cardiovasc Res, 64, 421-30 (2004). (Pubitemid 39505421)
128. Braren, R., H. Hu, Y. H. Kim, H. E. Beggs, L. F. Reichardt & R. Wang: Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol, 172, 151-62 (2006). (Pubitemid 43042637)
129. Shen, T. L., A. Y. Park, A. Alcaraz, X. Peng, I. Jang, P. Koni, R. A. Flavell, H. Gu & J. L. Guan: Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol, 169, 941-52 (2005). (Pubitemid 41002870)
130. Furuta, Y., D. Ilic, S. Kanazawa, N. Takeda, T. Yamamoto & S. Aizawa: Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. Oncogene, 11, 1989-95 (1995).
131. Peng, X., M. S. Kraus, H. Wei, T. L. Shen, R. Pariaut, A. Alcaraz, G. Ji, L. Cheng, Q. Yang, M. I. Kotlikoff, J. Chen, K. Chien, H. Gu & J. L. Guan: Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest, 116, 217-27 (2006). (Pubitemid 43121807)
132. DiMichele, L. A., J. T. Doherty, M. Rojas, H. E. Beggs, L. F. Reichardt, C. P. Mack & J. M. Taylor: Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy. Circ Res, 99, 636-45 (2006). (Pubitemid 44401455)
133. Hannigan, G. E., C. Leung-Hagesteijn, L. Fitz-Gibbon, M. G. Coppolino, G. Radeva, J. Filmus, J. C. Bell & S. Dedhar: Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature, 379, 91-6 (1996). (Pubitemid 26008142)
134. Pasquet, J. M., M. Noury & A. T. Nurden: Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway. Thromb Haemost, 88, 115-22 (2002). (Pubitemid 34752276)
135. Hannigan, G. E., J. Bayani, R. Weksberg, B. Beatty, A. Pandita, S. Dedhar & J. Squire: Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15.5-p15.4. Genomics, 42, 177-9 (1997). (Pubitemid 27215142)
136. Melchior, C., S. Kreis, B. Janji & N. Kieffer: Promoter characterization and genomic organization of the gene encoding integrin-linked kinase 1. Biochim Biophys Acta, 1575, 117-22 (2002). (Pubitemid 34521784)
137. Huang, Y., J. Li, Y. Zhang & C. Wu: The roles of integrin-linked kinase in the regulation of myogenic differentiation. J Cell Biol, 150, 861-72 (2000).
138. Friedrich, E. B., E. Liu, S. Sinha, S. Cook, D. S. Milstone, C. A. MacRae, M. Mariotti, P. J. Kuhlencordt, T. Force, A. Rosenzweig, R. St-Arnaud, S. Dedhar & R. E. Gerszten: Integrin-linked kinase regulates endothelial cell survival and vascular development. Mol Cell Biol, 24, 8134-44 (2004). (Pubitemid 39167462)
139. Sepulveda, J. L. & C. Wu: The parvins. Cell Mol Life Sci, 63, 25-35 (2006). (Pubitemid 43100278)
140. Sakai, T., S. Li, D. Docheva, C. Grashoff, K. Sakai, G. Kostka, A. Braun, A. Pfeifer, P. D. Yurchenco & R. Fassler: Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev, 17, 926-40 (2003). (Pubitemid 36397379)
141. Tu, Y., F. Li, S. Goicoechea & C. Wu: The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol, 19, 2425-34 (1999). (Pubitemid 29098300)
142. Leung-Hagesteijn, C., A. Mahendra, I. Naruszewicz & G. E. Hannigan: Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. Embo J, 20, 2160-70 (2001). (Pubitemid 32410586)
143. Rearden, A.: A new LIM protein containing an autoepitope homologous to "senescent cell antigen". Biochem Biophys Res Commun, 201, 1124-31 (1994).
144. Zhang, Y., K. Chen, L. Guo & C. Wu: Characterization of PINCH-2, a new focal adhesion protein that regulates the PINCH-1-ILK interaction, cell spreading, and migration. J Biol Chem, 277, 38328-38 (2002). (Pubitemid 35154687)
145. Dedhar, S., B. Williams & G. Hannigan: Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol, 9, 319-23 (1999). (Pubitemid 29339148)
146. Sepulveda, J. L., V. Gkretsi & C. Wu: Assembly and signaling of adhesion complexes. Curr Top Dev Biol, 68, 183-225 (2005). (Pubitemid 43588864)
147. Mackinnon, A. C., H. Qadota, K. R. Norman, D. G. Moerman & B. D. Williams: C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol, 12, 787-97 (2002). (Pubitemid 34514364)
148. Fukuda, T., K. Chen, X. Shi & C. Wu: PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J Biol Chem, 278, 51324-33 (2003). (Pubitemid 38020371)
149. Zhang, Y., K. Chen, Y. Tu, A. Velyvis, Y. Yang, J. Qin & C. Wu: Assembly of the PINCH-ILK-CH-ILKBP complex precedes and is essential for localization of each component to cell-matrix adhesion sites. J Cell Sci, 115, 4777-86 (2002). (Pubitemid 36054631)
150. Delcommenne, M., C. Tan, V. Gray, L. Rue, J. Woodgett & S. Dedhar: Phosphoinositide-3-OH kinasedependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A, 95, 11211-6 (1998). (Pubitemid 28450107)
151. Wu, C. & S. Dedhar: Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol, 155, 505-10 (2001). (Pubitemid 34289309)
152. Kumar, A. S., I. Naruszewicz, P. Wang, C. Leung-Hagesteijn & G. E. Hannigan: ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene, 23, 3454-61 (2004). (Pubitemid 38669835)
153. Persad, S., A. A. Troussard, T. R. McPhee, D. J. Mulholland & S. Dedhar: Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol, 153, 1161-74 (2001).
154. Troussard, A. A., N. M. Mawji, C. Ong, A. Mui, R. St-Arnaud & S. Dedhar: Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem, 278, 22374-8 (2003). (Pubitemid 36830287)
155. Lynch, D. K., C. A. Ellis, P. A. Edwards & I. D. Hiles: Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene, 18, 8024-32 (1999). (Pubitemid 30050563)
156. Hill, M. M., J. Feng & B. A. Hemmings: Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr Biol, 12, 1251-5 (2002). (Pubitemid 34801175)
157. Grashoff, C., A. Aszodi, T. Sakai, E. B. Hunziker & R. Fassler: Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep, 4, 432-8 (2003). (Pubitemid 36622011)
158. White, D. E., P. Coutu, Y. F. Shi, J. C. Tardif, S. Nattel, R. St Arnaud, S. Dedhar & W. J. Muller: Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev, 20, 2355-60 (2006). (Pubitemid 44320384)
159. Hannigan, G. E., J. G. Coles & S. Dedhar: Integrin-linked kinase at the heart of cardiac contractility, repair, and disease. Circ Res, 100, 1408-14 (2007). (Pubitemid 46834753)
160. Johnatty, S. E., J. R. Dyck, L. H. Michael, E. N. Olson & M. Abdellatif: Identification of genes regulated during mechanical load-induced cardiac hypertrophy. J Mol Cell Cardiol, 32, 805-15 (2000). (Pubitemid 30658917)
161. Bock-Marquette, I., A. Saxena, M. D. White, J. M. Dimaio & D. Srivastava: Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432, 466-72 (2004). (Pubitemid 39576522)
162. Akazawa, H., S. Kudoh, N. Mochizuki, N. Takekoshi, H. Takano, T. Nagai & I. Komuro: A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5. J Cell Biol, 164, 395-405 (2004). (Pubitemid 38174767)
163. Chen, H., X. N. Huang, W. Yan, K. Chen, L. Guo, L. Tummalapali, S. Dedhar, R. St-Arnaud, C. Wu & J. L. Sepulveda: Role of the integrin-linked kinase/PINCH1/alpha-parvin complex in cardiac myocyte hypertrophy. Lab Invest, 85, 1342-56 (2005). (Pubitemid 41509383)
164. Bellacosa, A., J. R. Testa, S. P. Staal & P. N. Tsichlis: A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science, 254, 274-7 (1991). (Pubitemid 21917339)
165. Coffer, P. J. & J. R. Woodgett: Molecular cloning and characterisation of a novel putative protein-serine kinase related to the cAMP-dependent and protein kinase C families. Eur J Biochem, 201, 475-81 (1991).
166. DeBosch, B., I. Treskov, T. S. Lupu, C. Weinheimer, A. Kovacs, M. Courtois & A. J. Muslin: Akt1 is required for physiological cardiac growth. Circulation, 113, 2097-104 (2006).
167. Condorelli, G., A. Drusco, G. Stassi, A. Bellacosa, R. Roncarati, G. Iaccarino, M. A. Russo, Y. Gu, N. Dalton, C. Chung, M. V. Latronico, C. Napoli, J. Sadoshima, C. M. Croce & J. Ross Jr.: Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A, 99, 12333-8 (2002).
168. Matsui, T., J. Tao, F. del Monte, K. H. Lee, L. Li, M. Picard, T. L. Force, T. F. Franke, R. J. Hajjar & A. Rosenzweig: Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation, 104, 330-5 (2001). (Pubitemid 32666956)
169. Shioi, T., J. R. McMullen, P. M. Kang, P. S. Douglas, T. Obata, T. F. Franke, L. C. Cantley & S. Izumo: Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol, 22, 2799-809 (2002). (Pubitemid 34263000)
170. Oudit, G. Y., H. Sun, B. G. Kerfant, M. A. Crackower, J. M. Penninger & P. H. Backx: The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol, 37, 449-71 (2004). (Pubitemid 38953373)
171. Luo, J., J. R. McMullen, C. L. Sobkiw, L. Zhang, A. L. Dorfman, M. C. Sherwood, M. N. Logsdon, J. W. Horner, R. A. DePinho, S. Izumo & L. C. Cantley: Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol, 25, 9491-502 (2005). (Pubitemid 41507849)
172. O'Neill, B. T., J. Kim, A. R. Wende, H. A. Theobald, J. Tuinei, J. Buchanan, A. Guo, V. G. Zaha, D. K. Davis, J. C. Schell, S. Boudina, B. Wayment, S. E. Litwin, T. Shioi, S. Izumo, M. J. Birnbaum & E. D. Abel: A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab, 6, 294-306 (2007). (Pubitemid 47450187)
173. Fernandez-Hernando, C., E. Ackah, J. Yu, Y. Suarez, T. Murata, Y. Iwakiri, J. Prendergast, R. Q. Miao, M. J. Birnbaum & W. C. Sessa: Loss of akt1 leads to severe atherosclerosis and occlusive coronary artery disease. Cell Metab, 6, 446-57 (2007). (Pubitemid 350163050)
174. Ye, C., L. Bai, Z. Q. Yan, Y. H. Wang & Z. L. Jiang: Shear stress and vascular smooth muscle cells promote endothelial differentiation of endothelial progenitor cells via activation of Akt. Clin Biomech (Bristol, Avon) (2007).
175. Chen, R., O. Kim, J. Yang, K. Sato, K. M. Eisenmann, J. McCarthy, H. Chen & Y. Qiu: Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem, 276, 31858-62 (2001).
176. Conus, N. M., K. M. Hannan, B. E. Cristiano, B. A. Hemmings & R. B. Pearson: Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J Biol Chem, 277, 38021-8 (2002). (Pubitemid 35154653)
177. Hresko, R. C. & M. Mueckler: mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem, 280, 40406-16 (2005). (Pubitemid 41780527)
178. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen & B. A. Hemmings: Mechanism of activation of protein kinase B by insulin and IGF-1. Embo J, 15, 6541-51 (1996). (Pubitemid 26413787)
179. Blume-Jensen, P. & T. Hunter: Oncogenic kinase signalling. Nature, 411, 355-65 (2001). (Pubitemid 32467045)
180. Sarbassov, D. D., D. A. Guertin, S. M. Ali & D. M. Sabatini: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science, 307, 1098-101 (2005). (Pubitemid 40262113)
181. Kawakami, Y., H. Nishimoto, J. Kitaura, M. Maeda-Yamamoto, R. M. Kato, D. R. Littman, M. Leitges, D. J. Rawlings & T. Kawakami: Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type-and stimulus-specific fashion. J Biol Chem, 279, 47720-5 (2004). (Pubitemid 39540919)
182. Chen, H. C., P. A. Appeddu, H. Isoda & J. L. Guan: Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J Biol Chem, 271, 26329-34 (1996). (Pubitemid 26347485)
183. Velling, T., S. Nilsson, A. Stefansson & S. Johansson: beta1-Integrins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases. EMBO Rep, 5, 901-5 (2004). (Pubitemid 350011236)
184. Takenawa, T. & H. Miki: WASP and WAVE family proteins: key molecules for rapid rearrangement of cortical actin filaments and cell movement. J Cell Sci, 114, 1801-9 (2001). (Pubitemid 32530035)
185. Ridley, A. J.: Rho GTPases and cell migration. J Cell Sci, 114, 2713-22 (2001). (Pubitemid 32785451)
186. Burridge, K. & K. Wennerberg: Rho and Rac take center stage. Cell, 116, 167-79 (2004). (Pubitemid 38167310)
187. Bustelo, X. R., V. Sauzeau & I. M. Berenjeno: GTPbinding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays, 29, 356-70 (2007). (Pubitemid 46597867)
188. Jaffe, A. B. & A. Hall: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol, 21, 247-69 (2005). (Pubitemid 41740635)
189. Bishop, A. L. & A. Hall: Rho GTPases and their effector proteins. Biochem J, 348 Pt 2, 241-55 (2000). (Pubitemid 30345195)
190. Fukata, Y., M. Amano & K. Kaibuchi: Rho-Rhokinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci, 22, 32-9 (2001). (Pubitemid 32126284)
191. Kimura, K., M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamori, J. Feng, T. Nakano, K. Okawa, A. Iwamatsu & K. Kaibuchi: Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase) Science, 273, 245-8 (1996). (Pubitemid 26285892)
192. Noda, M., C. Yasuda-Fukazawa, K. Moriishi, T. Kato, T. Okuda, K. Kurokawa & Y. Takuwa: Involvement of rho in GTP gamma S-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett, 367, 246-50 (1995).
193. Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki & J. S. Gutkind: The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 81, 1137-46 (1995).
194. Minden, A., A. Lin, F. X. Claret, A. Abo & M. Karin: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81, 1147-57 (1995).
195. Puls, A., A. G. Eliopoulos, C. D. Nobes, T. Bridges, L. S. Young & A. Hall: Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF (alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1. J Cell Sci, 112 (Pt 17), 2983-92 (1999). (Pubitemid 29430043)
196. Burbelo, P. D., D. Drechsel & A. Hall: A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases. J Biol Chem, 270, 29071-4 (1995).
197. Gallagher, E. D., S. Gutowski, P. C. Sternweis & M. H. Cobb: RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem, 279, 1872-7 (2004). (Pubitemid 38084456)
198. Teramoto, H., O. A. Coso, H. Miyata, T. Igishi, T. Miki & J. S. Gutkind: Signaling from the small GTP-binding proteins Rac1 and Cdc42 to the c-Jun N-terminal kinase/stress-activated protein kinase pathway. A role for mixed lineage kinase 3/protein-tyrosine kinase 1, a novel member of the mixed lineage kinase family. J Biol Chem, 271, 27225-8 (1996). (Pubitemid 26367270)
199. Teramoto, H., P. Crespo, O. A. Coso, T. Igishi, N. Xu & J. S. Gutkind: The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pakindependent signaling pathway. J Biol Chem, 271, 25731-4 (1996). (Pubitemid 26347396)
200. Schlessinger, J.: How receptor tyrosine kinases activate Ras. Trends Biochem Sci, 18, 273-5 (1993). (Pubitemid 23233561)
201. Schwartz, M.: Rho signalling at a glance. J Cell Sci, 117, 5457-8 (2004). (Pubitemid 40012192)
202. Uehata, M., T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa & S. Narumiya: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature, 389, 990-4 (1997). (Pubitemid 27485693)
203. Katsumata, N., H. Shimokawa, M. Seto, T. Kozai, T. Yamawaki, K. Kuwata, K. Egashira, I. Ikegaki, T. Asano, Y. Sasaki & A. Takeshita: Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. Circulation, 96, 4357-63 (1997). (Pubitemid 28007466)
204. Klein, S., A. R. de Fougerolles, P. Blaikie, L. Khan, A. Pepe, C. D. Green, V. Koteliansky & F. G. Giancotti: Alpha 5 beta 1 integrin activates an NF-kappa B-dependent program of gene expression important for angiogenesis and inflammation. Mol Cell Biol, 22, 5912-22 (2002). (Pubitemid 34815839)
205. Wang, S. M., Y. J. Tsai, M. J. Jiang & Y. Z. Tseng: Studies on the function of rho A protein in cardiac myofibrillogenesis. J Cell Biochem, 66, 43-53 (1997).
206. Thorburn, J., S. Xu & A. Thorburn: MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. Embo J, 16, 1888-900 (1997). (Pubitemid 27170950)
207. Satoh, M., H. Ogita, K. Takeshita, Y. Mukai, D. J. Kwiatkowski & J. K. Liao: Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci U S A, 103, 7432-7 (2006). (Pubitemid 43727850)
208. Zhang, Y. M., J. Bo, G. E. Taffet, J. Chang, J. Shi, A. K. Reddy, L. H. Michael, M. D. Schneider, M. L. Entman, R. J. Schwartz & L. Wei: Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. Faseb J, 20, 916-25 (2006). (Pubitemid 44943949)
209. Rikitake, Y., N. Oyama, C. Y. Wang, K. Noma, M. Satoh, H. H. Kim & J. K. Liao: Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/-haploinsufficient mice. Circulation, 112, 2959-65 (2005). (Pubitemid 41612298)
210. Hattori, T., H. Shimokawa, M. Higashi, J. Hiroki, Y. Mukai, H. Tsutsui, K. Kaibuchi & A. Takeshita: Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation, 109, 2234-9 (2004). (Pubitemid 38625402)
211. Sussman, M. A., S. Welch, A. Walker, R. Klevitsky, T. E. Hewett, R. L. Price, E. Schaefer & K. Yager: Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1. J Clin Invest, 105, 875-86 (2000). (Pubitemid 30203060)
212. Pracyk, J. B., K. Tanaka, D. D. Hegland, K. S. Kim, R. Sethi, Rovira, II, D. R. Blazina, L. Lee, J. T. Bruder, I. Kovesdi, P. J. Goldshmidt-Clermont, K. Irani & T. Finkel: A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J Clin Invest, 102, 929-37 (1998). (Pubitemid 28419238)
213. Price, L. S., J. Leng, M. A. Schwartz & G. M. Bokoch: Activation of Rac and Cdc42 by integrins mediates cell spreading. Mol Biol Cell, 9, 1863-71 (1998). (Pubitemid 28337528)
214. Boulton, T. G., S. H. Nye, D. J. Robbins, N. Y. Ip, E. Radziejewska, S. D. Morgenbesser, R. A. DePinho, N. Panayotatos, M. H. Cobb & G. D. Yancopoulos: ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell, 65, 663-75 (1991).
215. Sugden, P. H. & A. Clerk: "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res, 83, 345-52 (1998). (Pubitemid 28389964)
216. Kyriakis, J. M., P. Banerjee, E. Nikolakaki, T. Dai, E. A. Rubie, M. F. Ahmad, J. Avruch & J. R. Woodgett: The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 369, 156-60 (1994). (Pubitemid 24153440)
217. Gupta, S., T. Barrett, A. J. Whitmarsh, J. Cavanagh, H. K. Sluss, B. Derijard & R. J. Davis: Selective interaction of JNK protein kinase isoforms with transcription factors. Embo J, 15, 2760-70 (1996). (Pubitemid 26176253)
218. New, L. & J. Han: The p38 MAP kinase pathway and its biological function. Trends Cardiovasc Med, 8, 220-8 (1998). (Pubitemid 28345826)
219. Liang, Q. & J. D. Molkentin: Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol, 35, 1385-94 (2003). (Pubitemid 37491181)
220. Sadoshima, J. & S. Izumo: Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. Embo J, 12, 1681-92 (1993). (Pubitemid 23112823)
221. Sopontammarak, S., A. Aliharoob, C. Ocampo, R. A. Arcilla, M. P. Gupta & M. Gupta: Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy. Cell Biochem Biophys, 43, 61-76 (2005). (Pubitemid 41095274)
222. Bogoyevitch, M. A., M. B. Andersson, J. Gillespie-Brown, A. Clerk, P. E. Glennon, S. J. Fuller & P. H. Sugden: Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J, 314 (Pt 1), 115-21 (1996). (Pubitemid 26063840)
223. Gillespie-Brown, J., S. J. Fuller, M. A. Bogoyevitch, S. Cowley & P. H. Sugden: The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem, 270, 28092-6 (1995).
224. Ramirez, M. T., V. P. Sah, X. L. Zhao, J. J. Hunter, K. R. Chien & J. H. Brown: The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J Biol Chem, 272, 14057-61 (1997). (Pubitemid 27232807)
225. Nemoto, S., Z. Sheng & A. Lin: Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol Cell Biol, 18, 3518-26 (1998). (Pubitemid 28240524)
226. Bueno, O. F., L. J. De Windt, H. W. Lim, K. M. Tymitz, S. A. Witt, T. R. Kimball & J. D. Molkentin: The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res, 88, 88-96 (2001). (Pubitemid 32064088)
227. Lee, J. W. & R. Juliano: Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells, 17, 188-202 (2004). (Pubitemid 39137065)
228. Lin, T. H., A. E. Aplin, Y. Shen, Q. Chen, M. Schaller, L. Romer, I. Aukhil & R. L. Juliano: Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol, 136, 1385-95 (1997). (Pubitemid 27421923)
229. Krishnamurthy, P., V. Subramanian, M. Singh & K. Singh: Beta1 integrins modulate beta-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension, 49, 865-72 (2007). (Pubitemid 351664231)
230. Eliceiri, B. P.: Integrin and growth factor receptor crosstalk. Circ Res, 89, 1104-10 (2001). (Pubitemid 34627867)
231. Legate, K. R., E. Montanez, O. Kudlacek & R. Fassler: ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol, 7, 20-31 (2006). (Pubitemid 43361569)
232. Chen, Z., T. B. Gibson, F. Robinson, L. Silvestro, G. Pearson, B. Xu, A. Wright, C. Vanderbilt & M. H. Cobb: MAP kinases. Chem Rev, 101, 2449-76 (2001). (Pubitemid 35373029)
233. Assoian, R. K. & M. A. Schwartz: Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr Opin Genet Dev, 11, 48-53 (2001). (Pubitemid 32119277)
234. Juliano, R. L., A. E. Aplin, A. K. Howe, S. Short, J. W. Lee & S. Alahari: Integrin regulation of receptor tyrosine kinase and G protein-coupled receptor signaling to mitogen-activated protein kinases. Methods Enzymol, 333, 151-63 (2001). (Pubitemid 32507306)
235. Mahabeleshwar, G. H., W. Feng, K. Reddy, E. F. Plow & T. V. Byzova: Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res, 101, 570-80 (2007). (Pubitemid 351325874)
236. Chan, P. C., S. Y. Chen, C. H. Chen & H. C. Chen: Crosstalk between hepatocyte growth factor and integrin signaling pathways. J Biomed Sci, 13, 215-23 (2006).
237. Comoglio, P. M., C. Boccaccio & L. Trusolino: Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol, 15, 565-71 (2003). (Pubitemid 37176965)
238. Yoganathan, T. N., P. Costello, X. Chen, M. Jabali, J. Yan, D. Leung, Z. Zhang, A. Yee, S. Dedhar & J. Sanghera: Integrin-linked kinase (ILK): a "hot" therapeutic target. Biochem Pharmacol, 60, 1115-9 (2000).
239. Zhang, X., K. Hu & C. Y. Li: Protection against oxidized low-density lipoprotein-induced vascular endothelial cell death by integrin-linked kinase. Circulation, 104, 2762-6 (2001). (Pubitemid 33126647)
240. Zhang, Z. C., S. J. Li, Y. Z. Yang, R. Z. Chen, J. B. Ge & H. Z. Chen: Microarray analysis of extracellular matrix genes expression in myocardium of mouse with Coxsackie virus B3 myocarditis. Chin Med J (Engl), 117, 1228-31 (2004).
241. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter & et al.: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-46 (1994).
242. Adams, J. L., J. C. Boehm, S. Kassis, P. D. Gorycki, E. F. Webb, R. Hall, M. Sorenson, J. C. Lee, A. Ayrton, D. E. Griswold & T. F. Gallagher: Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorg Med Chem Lett, 8, 3111-6 (1998). (Pubitemid 28551630)
243. Boehm, J. C., J. M. Smietana, M. E. Sorenson, R. S. Garigipati, T. F. Gallagher, P. L. Sheldrake, J. Bradbeer, A. M. Badger, J. T. Laydon, J. C. Lee, L. M. Hillegass, D. E. Griswold, J. J. Breton, M. C. Chabot-Fletcher & J. L. Adams: 1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency. J Med Chem, 39, 3929-37 (1996). (Pubitemid 26327430)
244. Adams, J. L., J. C. Boehm, T. F. Gallagher, S. Kassis, E. F. Webb, R. Hall, M. Sorenson, R. Garigipati, D. E. Griswold & J. C. Lee: Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity. Bioorg Med Chem Lett, 11, 2867-70 (2001).
245. Liverton, N. J., J. W. Butcher, C. F. Claiborne, D. A. Claremon, B. E. Libby, K. T. Nguyen, S. M. Pitzenberger, H. G. Selnick, G. R. Smith, A. Tebben, J. P. Vacca, S. L. Varga, L. Agarwal, K. Dancheck, A. J. Forsyth, D. S. Fletcher, B. Frantz, W. A. Hanlon, C. F. Harper, S. J. Hofsess, M. Kostura, J. Lin, S. Luell, E. A. O'Neill, S. J. O'Keefe & et al.: Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem, 42, 2180-90 (1999). (Pubitemid 29284237)
246. Ju, H., S. Nerurkar, C. F. Sauermelch, A. R. Olzinski, R. Mirabile, D. Zimmerman, J. C. Lee, J. Adams, J. Sisko, M. Berova & R. N. Willette: Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury. J Pharmacol Exp Ther, 301, 15-20 (2002). (Pubitemid 34250274)
247. Behr, T. M., S. S. Nerurkar, A. H. Nelson, R. W. Coatney, T. N. Woods, A. Sulpizio, S. Chandra, D. P. Brooks, S. Kumar, J. C. Lee, E. H. Ohlstein, C. E. Angermann, J. L. Adams, J. Sisko, J. D. Sackner-Bernstein & R. N. Willette: Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation, 104, 1292-8 (2001). (Pubitemid 32848120)
248. See, F., W. Thomas, K. Way, A. Tzanidis, A. Kompa, D. Lewis, S. Itescu & H. Krum: p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol, 44, 1679-89 (2004). (Pubitemid 39369804)
249. Liu, Y. H., D. Wang, N. E. Rhaleb, X. P. Yang, J. Xu, S. S. Sankey, A. E. Rudolph & O. A. Carretero: Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction. J Card Fail, 11, 74-81 (2005). (Pubitemid 40215318)
250. Kyoi, S., H. Otani, S. Matsuhisa, Y. Akita, K. Tatsumi, C. Enoki, H. Fujiwara, H. Imamura, H. Kamihata & T. Iwasaka: Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster. Cardiovasc Res, 69, 888-98 (2006). (Pubitemid 43227987)
251. Zhang, S., J. Ren, C. E. Zhang, I. Treskov, Y. Wang & A. J. Muslin: Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ Res, 93, 1026-8 (2003). (Pubitemid 37485032)
252. Kumar, S., J. Boehm & J. C. Lee: p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov, 2, 717-26 (2003). (Pubitemid 37361787)
253. Makeeva, N., G. M. Roomans, J. W. Myers & N. Welsh: TAB1{alpha}, but not TAB1{beta}, mediates cytokine-induced p38 MAPK phosphorylation and cell death in insulin producing cells. Endocrinology (2007).
254. Reth, M. & T. Brummer: Feedback regulation of lymphocyte signalling. Nat Rev Immunol, 4, 269-77 (2004). (Pubitemid 38478662)
255. Cheung, P. C., D. G. Campbell, A. R. Nebreda & P. Cohen: Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. Embo J, 22, 5793-805 (2003). (Pubitemid 37408818)
256. Wang, Y., B. Su, V. P. Sah, J. H. Brown, J. Han & K. R. Chien: Cardiac hypertrophy induced by mitogenactivated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem, 273, 5423-6 (1998). (Pubitemid 28124000)
257. Choukroun, G., R. Hajjar, S. Fry, F. del Monte, S. Haq, J. L. Guerrero, M. Picard, A. Rosenzweig & T. Force: Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH (2)-terminal kinases. J Clin Invest, 104, 391-8 (1999). (Pubitemid 29534323)
258. Petrich, B. G. & Y. Wang: Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med, 14, 50-5 (2004). (Pubitemid 38340846)
259. Sadoshima, J., O. Montagne, Q. Wang, G. Yang, J. Warden, J. Liu, G. Takagi, V. Karoor, C. Hong, G. L. Johnson, D. E. Vatner & S. F. Vatner: The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest, 110, 271-9 (2002). (Pubitemid 34787364)
260. Liang, Q., O. F. Bueno, B. J. Wilkins, C. Y. Kuan, Y. Xia & J. D. Molkentin: c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. Embo J, 22, 5079-89 (2003). (Pubitemid 37222028)
261. Wang, Y.: Mitogen-activated protein kinases in heart development and diseases. Circulation, 116, 1413-23 (2007). (Pubitemid 47417568)
262. Tachibana, H., C. Perrino, H. Takaoka, R. J. Davis, S. V. Naga Prasad & H. A. Rockman: JNK1 is required to preserve cardiac function in the early response to pressure overload. Biochem Biophys Res Commun, 343, 1060-6 (2006).
263. Minamino, T., T. Yujiri, P. J. Papst, E. D. Chan, G. L. Johnson & N. Terada: MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes. Proc Natl Acad Sci U S A, 96, 15127-32 (1999). (Pubitemid 30019776)
264. Fryer, R. M., H. H. Patel, A. K. Hsu & G. J. Gross: Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol, 281, H1184-92 (2001).
265. Manning, A. M. & R. J. Davis: Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov, 2, 554-65 (2003). (Pubitemid 37361747)
266. Amano, M., K. Chihara, N. Nakamura, T. Kaneko, Y. Matsuura & K. Kaibuchi: The COOH terminus of Rhokinase negatively regulates rho-kinase activity. J Biol Chem, 274, 32418-24 (1999).
267. Inokuchi, K., A. Ito, Y. Fukumoto, T. Matoba, A. Shiose, T. Nishida, M. Masuda, S. Morita & H. Shimokawa: Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery. J Cardiovasc Pharmacol, 44, 275-7 (2004). (Pubitemid 39129443)
268. Ishizaki, T., M. Uehata, I. Tamechika, J. Keel, K. Nonomura, M. Maekawa & S. Narumiya: Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol, 57, 976-83 (2000). (Pubitemid 30253382)
269. Nagaoka, T., K. A. Fagan, S. A. Gebb, K. G. Morris, T. Suzuki, H. Shimokawa, I. F. McMurtry & M. Oka: Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med, 171, 494-9 (2005). (Pubitemid 40444250)
270. Hunter, I., H. J. Cobban, P. Vandenabeele, D. J. MacEwan & G. F. Nixon: Tumor necrosis factor-alphainduced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation. Mol Pharmacol, 63, 714-21 (2003). (Pubitemid 36297345)
271. Somlyo, A. V., C. Phelps, C. Dipierro, M. Eto, P. Read, M. Barrett, J. J. Gibson, M. C. Burnitz, C. Myers & A. P. Somlyo: Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. Faseb J, 17, 223-34 (2003). (Pubitemid 36164392)
272. Qvigstad, E., I. Sjaastad, T. Brattelid, C. Nunn, F. Swift, J. A. Birkeland, K. A. Krobert, G. O. Andersen, O. M. Sejersted, J. B. Osnes, F. O. Levy & T. Skomedal: Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart. Circ Res, 97, 268-76 (2005). (Pubitemid 41105453)
273. Olivier Schueller, O., W. Tong, J. W. Ferkany & P. Sweetnam: Selective ROCK 2 Inhibition Attenuates Arterial Plaque Formation in an ApoE Knockout Mouse Model. Circulation, 114, II-228 (2006).
274. Alberts, A. W.: Discovery, biochemistry and biology of lovastatin. Am J Cardiol, 62, 10J-15J (1988). (Pubitemid 18263851)
275. Wassmann, S., A. Faul, B. Hennen, B. Scheller, M. Bohm & G. Nickenig: Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ Res, 93, e98-103 (2003).
276. Laufs, U., V. La Fata, J. Plutzky & J. K. Liao: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation, 97, 1129-35 (1998). (Pubitemid 28152885)
277. Shiga, N., K. Hirano, M. Hirano, J. Nishimura, H. Nawata & H. Kanaide: Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Circ Res, 96, 1014-21 (2005). (Pubitemid 40712802)
278. Luo, J. D., W. W. Zhang, G. P. Zhang, J. X. Guan & X. Chen: Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol, 26, 903-8 (1999). (Pubitemid 29513630)
279. Luo, J. D., W. W. Zhang, G. P. Zhang, B. H. Zhong & H. J. Ou: Effects of simvastatin on activities of endogenous antioxidant enzymes and angiotensin-converting enzyme in rat myocardium with pressure-overload cardiac hypertrophy. Acta Pharmacol Sin, 23, 124-8 (2002).
280. Moiseeva, O. M., E. G. Semyonova, E. V. Polevaya & G. P. Pinayev: Effect of pravastatin on phenotypical transformation of fibroblasts and hypertrophy of cardiomyocytes in culture. Bull Exp Biol Med, 143, 54-7 (2007). (Pubitemid 46784874)
281. Planavila, A., R. Rodriguez-Calvo, X. Palomer, T. Coll, R. M. Sanchez, M. Merlos, J. C. Laguna & M. Vazquez-Carrera: Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli. Biochim Biophys Acta (2007).
282. Yndestad, A., T. Ueland, E. Oie, G. Florholmen, B. Halvorsen, H. Attramadal, S. Simonsen, S. S. Froland, L. Gullestad, G. Christensen, J. K. Damas & P. Aukrust: Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation, 109, 1379-85 (2004). (Pubitemid 38387824)
283. Gullestad, L., E. Oie, T. Ueland, A. Yndestad & P. Aukrust: The role of statins in heart failure. Fundam Clin Pharmacol, 21 Suppl 2, 35-40 (2007). (Pubitemid 350132295)
284. Lu, H., P. W. Fedak, X. Dai, C. Du, Y. Q. Zhou, M. Henkelman, P. S. Mongroo, A. Lau, H. Yamabi, A. Hinek, M. Husain, G. Hannigan & J. G. Coles: Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation, 114, 2271-9 (2006). (Pubitemid 44789501)